Advertisement

Advertisement

ANIK Stock Latest News

Anika Therapeutics Signals Momentum Amid Regulatory Hurdles

Company AnnouncementsAnika Therapeutics Signals Momentum Amid Regulatory Hurdles

Anika Therapeutics reports Q1 EPS 27c vs.(6c) last year

PremiumThe Fly

Anika Therapeutics reports Q1 EPS 27c vs.(6c) last year

19d ago

Anika Therapeutics Posts Strong Q1 2026 Revenue Growth

PremiumCompany Announcements

Anika Therapeutics Posts Strong Q1 2026 Revenue Growth

19d ago

Anika Therapeutics, Inc. (ANIK) Q1 Earnings Cheat Sheet

PremiumPre-Earnings

Anika Therapeutics, Inc. (ANIK) Q1 Earnings Cheat Sheet

21d ago

Anika Therapeutics Earnings Call Signals Cautious Rebound

PremiumCompany Announcements

Anika Therapeutics Earnings Call Signals Cautious Rebound

2M ago

Anika Therapeutics price target raised to $17 from $16 at Barrington

PremiumThe FlyAnika Therapeutics price target raised to $17 from $16 at Barrington

3M ago

Anika Therapeutics price target raised to $18 from $16 at B. Riley

The Fly

Anika Therapeutics price target raised to $18 from $16 at B. Riley

3M ago

Anika Announces Executive Transition Amid Stable Quarterly Results

Company Announcements

Anika Announces Executive Transition Amid Stable Quarterly Results

3M ago

Anika Therapeutics reports Q4 EPS 31c vs (3c) last year

PremiumThe Fly

Anika Therapeutics reports Q4 EPS 31c vs (3c) last year

3M ago

Anika Therapeutics sees FY26 revenue $114M-$122.5M

PremiumThe Fly

Anika Therapeutics sees FY26 revenue $114M-$122.5M

3M ago

ANIK Upcoming Earnings Report: What to Expect?

PremiumPre-Earnings

ANIK Upcoming Earnings Report: What to Expect?

3M ago

Anika Therapeutics Announces CEO Transition and Governance Changes

PremiumCompany Announcements

Anika Therapeutics Announces CEO Transition and Governance Changes

4M ago

Anika Therapeutics appoints Griffin as CEO, Blanchard as Executive Chair

PremiumThe FlyAnika Therapeutics appoints Griffin as CEO, Blanchard as Executive Chair

4M ago

Anika Therapeutics price target raised to $16 from $15 at Barrington

The Fly

Anika Therapeutics price target raised to $16 from $15 at Barrington

6M ago

Anika Therapeutics Reports Mixed Q3 2025 Results

Company Announcements

Anika Therapeutics Reports Mixed Q3 2025 Results

6M ago

Anika Therapeutics’ Earnings Call: Growth Amid Challenges

PremiumCompany Announcements

Anika Therapeutics’ Earnings Call: Growth Amid Challenges

6M ago

Anika Therapeutics Files Final Module for Hyalofast

PremiumCompany Announcements

Anika Therapeutics Files Final Module for Hyalofast

6M ago

Anika reports filing of final PMA module for Hylofast cartilage repair

PremiumThe Fly

Anika reports filing of final PMA module for Hylofast cartilage repair

6M ago

Anika Therapeutics reaffirms FY25 guidance

PremiumThe Fly

Anika Therapeutics reaffirms FY25 guidance

6M ago

Anika Therapeutics commences $15M 10b5-1 share repurchase

PremiumThe FlyAnika Therapeutics commences $15M 10b5-1 share repurchase

6M ago

Anika Therapeutics reports Q3 adjusted EPS 4c vs. 7c last year

The Fly

Anika Therapeutics reports Q3 adjusted EPS 4c vs. 7c last year

6M ago

Is ANIK a Buy, Before Earnings?

Pre-Earnings

Is ANIK a Buy, Before Earnings?

7M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >